Immunic AG | Finanzwire

Basculer en Français

10591	Companies
224565	Keywords
153304	Articles
118791	Press releases

Home
Companies
Immunic AG

BRIEF

published on 06/10/2026 at 12:35, 7 days 10 hours ago

Immunic Engages in Key Conferences this June

Oral Therapies Neurologic Diseases Immunic Participation Biotechnology Conferences IMU-856 Presentation
PRESS RELEASE

published on 06/10/2026 at 12:30, 7 days 10 hours ago

Immunic to Participate in Investor, Industry and Scientific Conferences in June
Immunic, Inc. to participate in investor, industry, and scientific conferences in June. Presentation on IMU-856 at EFMC-ACSMEDI Symposium

Conférences Investor Immunic Inc. Symposium IMU-856
BRIEF

published on 05/28/2026 at 12:35, 20 days 10 hours ago

Immunic Shares Phase 2 CALLIPER Trial Findings at CMSC Meeting 2026

Clinical Data Immunic Vidofludimus Calcium Progressive Multiple Sclerosis Phase 2 CALLIPER Trial
PRESS RELEASE

published on 05/28/2026 at 12:30, 20 days 10 hours ago

Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
Immunic to present additional Phase 2 CALLIPER Trial data for Vidofludimus Calcium at CMSC Annual Meeting 2026, reinforcing its potential in progressive multiple sclerosis

Immunic Vidofludimus Calcium Phase 2 Progressive Multiple Sclerosis CALLIPER Trial
BRIEF

published on 05/27/2026 at 12:35, 21 days 10 hours ago

Immunic Appoints Erik Lundgren as New CEO

Multiple Sclerosis Immunic Vidofludimus Calcium Phase 3 Trials Erik Lundgren
PRESS RELEASE

published on 05/27/2026 at 12:30, 21 days 10 hours ago

Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
Immunic appoints Erik Lundgren as CEO to lead transition to commercial-stage MS company. Lundgren's extensive biopharmaceutical experience brings strategic and operational expertise to Immunic

Biopharmaceutical CEO Multiple Sclerosis Immunic Erik Lundgren
BRIEF

published on 05/19/2026 at 12:35, 29 days 10 hours ago

Immunic Appoints Michael W. Bonney as Chair of the Board

Multiple Sclerosis Vidofludimus Calcium Biopharmaceutical Leadership Michael W. Bonney Immunic Board
PRESS RELEASE

published on 05/19/2026 at 12:30, 29 days 10 hours ago

Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
Immunic appoints Michael W. Bonney as Board Chair, bringing over 30 years of biopharmaceutical experience. Bonney led successful commercialization of Avonex® for MS. Exciting plans for future therapies

Biopharmaceutical Immunic Board Chair Michael W. Bonney Avonex
BRIEF

published on 05/13/2026 at 12:35, 1 month 4 days ago

Immunic, Inc. Reports Key Financial and Strategic Updates for Q1 2026

Immunic, Inc. Multiple Sclerosis Vidofludimus Calcium Q1 2026 Results Biotechnology Funding
PRESS RELEASE

published on 05/13/2026 at 12:30, 1 month 4 days ago

Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
Immunic, Inc. announces First Quarter 2026 Financial Results and corporate updates including appointment of Michael A. Panzara, M.D., M.P.H. as Chief Medical Officer and progress in ENSURE Trials for MS treatment

Financial Results Corporate Update Immunic Inc. First Quarter 2026 Michael A. Panzara

Accesswire

Published on 06/17/2026 at 22:50, 35 minutes ago

International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 55 minutes ago

Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 6 hours 30 minutes ago

Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors
Published on 06/17/2026 at 16:45, 6 hours 40 minutes ago

Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean
Published on 06/17/2026 at 14:30, 8 hours 55 minutes ago

Solitario Advances 2026 Ponderosa Drilling Program

View all ACCESSWIRE

EQS Group

Published on 06/17/2026 at 21:40, 1 hour 44 minutes ago

Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus Hackathon
Published on 06/17/2026 at 19:10, 4 hours 15 minutes ago

Africa Finance Corporation and Leading Italian Institutions Sign Strategic Cooperation Agreements at AFC-Italy Forum to Mobilise Capital and Accelerate Industrial Development Across Africa
Published on 06/17/2026 at 18:40, 4 hours 45 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/17/2026 at 18:36, 4 hours 49 minutes ago

BILENDI: Bilendi announces that Euroland Corporate has initiated coverage of its shares
Published on 06/17/2026 at 18:23, 5 hours 2 minutes ago

EQS-Adhoc: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: Conclusion of a delisting agreement with Bayerische Gewerbebau AG

Les Echos

Published on 06/17/2026 at 17:40, 5 hours 45 minutes ago

Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 14 hours 40 minutes ago

Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 11 hours ago

Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 2 days ago

BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 2 days 4 hours ago

Reporting on share buyback transactions carried out between June 8 and June 11, 2026

View all LES ECHOS COMFI WIRE